LOGIN
AAOS 2024: Autologous Chondrocyte Implantation vs. Microfracture for Knee Cartilage Defects
February 2024
AAOS 2024: Autologous Chondrocyte Implantation vs. Microfracture for Knee Cartilage Defects
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Costal Chondrocyte-Derived Pellet-Type Autologous Chondrocyte Implantation for Treatment of Articular Cartilage Defect: A Five-Year Follow Up of a Prospective Randomized Trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
This abstract presents the 5-year follow-up results of a previously published prospective randomized controlled trial. 30 patients with an International Cartilage Repair Society (ICRS) grade 3 to 4 chondral defect in the knee were randomized to receive costal chondrocyte–derived pellet-type autologous chondrocyte implantation (CCP-ACI; n=20) or microfracture (MFx; n=10). 25 of these patients were ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.